Literature DB >> 18265996

Interaction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes.

Toke Bek1, Javad Hajari, Peter Jeppesen.   

Abstract

BACKGROUND: Diabetic retinopathy is accompanied with changes in the autoregulation of retinal blood flow secondary to changes in the systemic blood pressure and the retinal metabolism. In the present study we tested the working hypothesis that there is an interaction between these mechanisms that might be relevant for understanding and treating flow disturbances in diabetic retinopathy.
METHODS: Fifty-four persons divided into three age and sex matched groups were studied: Group 1: twenty normal persons. Group 2: fourteen patients with type 2 diabetes mellitus and no diabetic retinopathy. Group 3: twenty type 2 diabetic patients with minimal diabetic retinopathy and a diabetes duration similar to that of the patients in group 2. Using the Retinal Vessel Analyzer (RVA) the diameter response of retinal arterioles was studied in all groups after an increase in the blood pressure by isometric exercise, during exposition to 8 Hz flickering light, and during simultaneous exposition to both stimulus conditions.
RESULTS: The increased blood pressure induced by isometric exercise induced a non-significant vasoconstriction in the normal persons and in the diabetic patients without retinopathy (p=0.10 and p=0.84 respectively), and a non-significant vasodilatation in the diabetic patients with mild retinopathy (p=0.10). The flicker stimulus elicited a significant vasodilatation of retinal arterioles that decreased significantly from the normal persons to the diabetic patients without and with retinopathy (linear regression, p<0.01). The flicker-induced vasodilatation was not significantly affected by a simultaneous increase in the arterial blood pressure in normal persons (p=0.85). Conversely, in the diabetic patients the reduced diameter response during flicker was counteracted by a simultaneous increase in the blood pressure, to a level not differing significantly from the response of normal persons (p=0.75).
CONCLUSIONS: Intervention studies aimed at modifying perfusion in retinal disease should consider the interaction between different mechanisms for autoregulating retinal blood flow. New treatment modalities for retinal vascular disease might need to target several mechanisms of tone control in retinal arterioles simultaneously.

Entities:  

Mesh:

Year:  2008        PMID: 18265996     DOI: 10.1007/s00417-008-0766-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Retinal blood flow regulation in diabetes mellitus: impaired autoregulation and No detectable effect of autonomic neuropathy using laser doppler velocimetry, computer assisted image analysis, and isometric exercise.

Authors:  M J Dumskyj; E M Kohner
Journal:  Microvasc Res       Date:  1999-05       Impact factor: 3.514

2.  Influence of flicker frequency on flicker-induced changes of retinal vessel diameter.

Authors:  Kaija Polak; Leopold Schmetterer; Charles E Riva
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

3.  Diffuse luminance flicker increases blood flow in major retinal arteries and veins.

Authors:  G Garhöfer; C Zawinka; H Resch; K H Huemer; G T Dorner; L Schmetterer
Journal:  Vision Res       Date:  2004-04       Impact factor: 1.886

4.  Response of retinal arteriole diameter to increased blood pressure during acute hyperglycaemia.

Authors:  Peter Jeppesen; Søren T Knudsen; Per L Poulsen; Carl E Mogensen; Ole Schmitz; Toke Bek
Journal:  Acta Ophthalmol Scand       Date:  2007-05

5.  Chorioretinal vascular oxygen tension changes in response to light flicker.

Authors:  Akbar Shakoor; Norman P Blair; Marek Mori; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

6.  Short-term increase of intraocular pressure does not alter the response of retinal and optic nerve head blood flow to flicker stimulation.

Authors:  Gerhard Garhöfer; Hemma Resch; Günther Weigert; Solveig Lung; Christian Simader; Leopold Schmetterer
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-05       Impact factor: 4.799

7.  The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy.

Authors:  Christian Alcaraz Frederiksen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Carl Erik Mogensen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

8.  Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes.

Authors:  G Garhöfer; C Zawinka; H Resch; P Kothy; L Schmetterer; G T Dorner
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

Review 9.  Control of retinal arterial tone by a paracrine retinal relaxing factor.

Authors:  Nele Maenhaut; Koen Boussery; Christophe Delaey; Johan Van de Voorde
Journal:  Microcirculation       Date:  2007-01       Impact factor: 2.628

10.  Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.

Authors:  S E Bursell; A C Clermont; B T Kinsley; D C Simonson; L M Aiello; H A Wolpert
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-04       Impact factor: 4.799

View more
  21 in total

1.  Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study.

Authors:  Line Pedersen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-01       Impact factor: 3.117

2.  Lack of correlation between short-term dynamics of diabetic retinopathy lesions and the arterial blood pressure.

Authors:  Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-03       Impact factor: 3.117

Review 3.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

Review 4.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

5.  Response of inner retinal oxygen extraction fraction to light flicker under normoxia and hypoxia in rat.

Authors:  Pang-yu Teng; Justin Wanek; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

6.  Impaired retinal vasodilator responses in prediabetes and type 2 diabetes.

Authors:  Mary E J Lott; Julia E Slocomb; Vikram Shivkumar; Bruce Smith; David Quillen; Robert A Gabbay; Thomas W Gardner; Kerstin Bettermann
Journal:  Acta Ophthalmol       Date:  2013-06-07       Impact factor: 3.761

Review 7.  Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.

Authors:  Maxwell S Stem; Thomas W Gardner
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Lack of effect of nitroglycerin on the diameter response of larger retinal arterioles in normal persons during hypoxia.

Authors:  Musa Yasin Kaya; Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-30       Impact factor: 3.117

9.  Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles.

Authors:  Travis W Hein; Robert H Rosa; Zhaoxu Yuan; Elizabeth Roberts; Lih Kuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

Review 10.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.